Munich, Germany – April 8, 2003 – Bicoll GmbH, Munich announced today the four members of the company’s Advisory Board. With Thorsten Bach, Ph.D., Hardy Debuch, Ph.D., K. Peter C. Vollhardt, Ph.D., and Sina Afra, MBA, the Bicoll-Group will strengthen …
Munich, Germany – August 6, 2002 – Bicoll Biotechnology (Shanghai) Co. Ltd., a 100% subsidiary of Bicoll GmbH, Germany, has successfully completed the Chinese company’s build-up process in Shanghai / P.R. China within one year only. The general manager of …
Munich, Germany – July 20, 2002 – Soon, patients who thought that they suffer from diseases with no cure available can expect effective treatment. This was one of the motivation, for the Bavarian ministry for science, research and arts to …
Munich, Germany – January 1, 2002 – Dr. Kai Lamottke has been appointed General Manager of Bicoll Biotechnology (Shanghai) Co. Ltd. (Shanghai). He has more than six years of experience in synthetic organic research. Lamottke received his Diploma in chemistry …
Munich, Germany – July 15, 2001 – Bicoll announced today to carry out a public-private-partnership- project. Bicoll’s public partner in that special environmental protection project will be the Deutsche Investitions- und Entwicklungsgesellschaft mbH (DEG). The DEG has a coordination function …
Munich, Germany – July 2, 2001 – Bicoll GmbH, Germany, announces the foundation of Bicoll Biotechnology (Shanghai) Co. Ltd., P.R. China. The Sino part of the company is a 100% subsidiary of Bicoll GmbH. “China is one of the most …
Munich, Germany – December 1, 2000 – Bicoll GmbH has been founded in Munich, Germany, one of Europe’s most interesting biotech “hotspots”. Bicoll’s mission is to accelerate the developing process of new drug candidates. The growing biotechnology company provides an …